For research use only. Not for therapeutic Use.
Xininurad（Cat No.:I043356）is a selective urate transporter 1 (URAT1) inhibitor that helps lower uric acid levels in the blood. By blocking URAT1, it reduces uric acid reabsorption in the kidneys, promoting its excretion and helping to manage conditions like gout and hyperuricemia. Xininurad is being explored as a potential treatment for patients who have not responded well to traditional therapies or have contraindications to other medications. Its targeted mechanism provides a promising option for long-term management of uric acid-related disorders, improving patient outcomes and quality of life.
| CAS Number | 2365178-28-3 |
| Synonyms | (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-6-fluoroimidazo[1,2-a]pyrimidin-3-yl)methanone |
| Molecular Formula | C15H10Br2FN3O2 |
| Purity | ≥95% |
| IUPAC Name | (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-6-fluoroimidazo[1,2-a]pyrimidin-3-yl)methanone |
| InChI | InChI=1S/C15H10Br2FN3O2/c1-2-11-12(21-6-8(18)5-19-15(21)20-11)13(22)7-3-9(16)14(23)10(17)4-7/h3-6,23H,2H2,1H3 |
| InChIKey | ACXPMDYWZAUOJS-UHFFFAOYSA-N |
| SMILES | CCC1=C(N2C=C(C=NC2=N1)F)C(=O)C3=CC(=C(C(=C3)Br)O)Br |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
